Nichi-Iko Records Double-digit Growth For 3Q
This article was originally published in PharmAsia News
Executive Summary
Nichi-Iko reported generic drug sales grew by 16.8 percent to ¥46.9 billion for the third quarter ending Aug. 31. Net profit also increased by 2.7 percent to ¥2.7 billion